[ PRINT ] [ Printing FAQ ] About OncoLink Editorial Board Sponsors Help See Today's OncoTip Usage Statistics Virtual Classroom Abramson Family Cancer Research Institute "Confronting Cancer Through Art" is an exhibition by people whose lives have been touched by cancer. This week we are featuring artwork by: Jacqueline Kniewasser Pontypool, Ontario Visit the Children's Art Gallery This week's artwork was donated by a pediatric cancer patient who received treatment for cancer at The Children's Hospital of Philadelphia.

OncoLink FAQ: Paget's Disease of the Nipple Last Revision Date: Sunday, 14-Feb-1999 13:54:29 EST Copyright © 1994-1999, The Trustees of the University of Pennsylvania This is a response to a question about Paget's disease of the nipple. Question: Can you please send me any information on Paget's disease of the nipple? Kenneth Blank, MD and John Han-Chih Chang, MD, Editorial Assistants for Oncolink, respond: Thank you for your question. Paget's disease of the nipple is a condition that is characterized by an inflamed, red, itchy nipple. These symptoms are due to the presence of Paget's cells in the skin of the nipple. Paget's cells are large, irregular cells that are themselves not cancerous, but are almost always associated with a cancer in the breast. Therefore, women who present with the symptoms of Paget's disease must have a thorough physical exam and a mammogram to determine if there is a cancer in the breast. The large majority of patients with Paget's disease may require a mastectomy. Adjuvant (post-surgery) therapy with either radiation, chemotherapy or both will be depend on the characteristics of the tumor.

GENERAL DISCLAIMER OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.

For further information, consult the Editors at: editors@oncolink.upenn.edu